Exactech’s business segments increased across the board in the second quarter, with the exception of its biologic and spine business, which decreased 1 percent to $5.9 million. The company’s revenue from knee implants increased 1 percent to $21 million; extremity implants increased 24 percent to $12 million; and hip implant increased 22 percent to $10.3 million.
More Articles on Orthopedic Devices:
Study to Compare Benvenue Medical, Medtronic Spinal Systems
National Capital Region Medical Adopts HemaClear Device
Medtronic Receives 510(k) Approval for Orthopedic Sealer
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
